Louise St. Germain Bannon: A Fantastic Start to ISTH 2026 and the Future of Thrombosis Research
Louise St. Germain Bannon, Interim Executive Director at International Society on Thrombosis and Haemostasis (ISTH), shared on LinkedIn:
”The first morning of ISTH 2026 is off to a fantastic start!
It has been wonderful to see our global community reconnecting in Paris and to spend time with Suzanne Cannegieter, Editor-in-Chief of the Journal of Thrombosis and Haemostasis (JTH), and Mike Makris, Editor-in-Chief of Research and Practice in Thrombosis and Haemostasis (RPTH).
As you’re inspired by the outstanding science being presented this week, I encourage you to consider the ISTH journals for your next manuscript.
They are journals you can trust for rigorous peer review, editorial excellence and a shared commitment to advancing science that improves patient care around the world.
Thank you, Suzanne and Mike, for your leadership and dedication to trusted scientific publishing.
Here are a few moments from the first morning of Congress.
We’re just getting started!”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 11:51Sumaiya Dickens: Marginal Zone B Cells in Transfusion Medicine and Hemophilia A Research
-
Oct 9, 2026, 11:44Ayyappan V Nair: PRP and Rehabilitation – Can It Help Athletes with Partial Rotator Cuff Tears?
-
Oct 9, 2026, 11:29Jigesha Dholakia: Supporting the Hemophilia Community Through the Unite Walk
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number